CORMEDIX INC.
|
||
(Exact Name of Registrant as Specified in Charter)
|
Delaware
|
001-34673
|
20-5894890
|
(State or Other Jurisdiction
of Incorporation)
|
(Commission File Number)
|
(IRS Employer
Identification No.)
|
1430 U.S. Highway 206, Suite 200, Bedminster, NJ |
07921
|
(Address of Principal Executive Offices) |
(Zip Code)
|
Registrant’s Telephone Number, Including Area Code: (908) 517-9500
|
745 Route 202-206, Suite 303, Bridgewater, NJ 08807
|
(Former address, if changed since last report)
|
o
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
o
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
o
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
o
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
(d)
|
Exhibits
|
|
Exhibit No.
|
Description
|
|
|
99.1
|
Press release dated March 9, 2015.
|
CORMEDIX INC.
|
|||
Date: March 9, 2015
|
By:
|
/s/ Randy Milby | |
Randy Milby | |||
Chief Executive Officer | |||